Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia
Maletzke, S; Salimi, A; Vieri, M; Schroeder, KM; Schemionek, M; Masouleh, BK; Brummendorf, TH; Koschmieder, S; Appelmann, I
Appelmann, I (通讯作者)，Rhein Westfal TH Aachen, Fac Med, Dept Hematol Oncol Hemostaseol & Stem Cell Transp, Aachen, Germany.;Appelmann, I (通讯作者)，Rhein Westfal TH Aachen, Fac Med, Ctr Integrated Oncol Aachen Bonn Cologne Duesseld, Aachen, Germany.;Appelmann, I (通讯作者)，Rhein Westfal TH Aachen, Fac Med, Dept Palliat Med, Aachen, Germany.
PLOS ONE, 2022; 17 (10):
